CN104107245A - Traditional Chinese medicine composition for treating antral gastritis - Google Patents
Traditional Chinese medicine composition for treating antral gastritis Download PDFInfo
- Publication number
- CN104107245A CN104107245A CN201410372182.5A CN201410372182A CN104107245A CN 104107245 A CN104107245 A CN 104107245A CN 201410372182 A CN201410372182 A CN 201410372182A CN 104107245 A CN104107245 A CN 104107245A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- radix
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 36
- 208000007882 Gastritis Diseases 0.000 title claims abstract description 23
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000010135 fructus aurantii immaturus Substances 0.000 claims abstract description 8
- 241000756943 Codonopsis Species 0.000 claims description 9
- 241000628997 Flos Species 0.000 claims description 9
- 241000222640 Polyporus Species 0.000 claims description 9
- 241000207929 Scutellaria Species 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 46
- 230000006870 function Effects 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 3
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 241000222684 Grifola Species 0.000 abstract 1
- 240000008866 Ziziphus nummularia Species 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 15
- 239000008280 blood Substances 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 230000036407 pain Effects 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 15
- 201000010099 disease Diseases 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 13
- 239000002253 acid Substances 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 230000002107 myocardial effect Effects 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 206010067171 Regurgitation Diseases 0.000 description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 208000001848 dysentery Diseases 0.000 description 7
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000000232 gallbladder Anatomy 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000003266 anti-allergic effect Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000001754 anti-pyretic effect Effects 0.000 description 5
- 239000002221 antipyretic Substances 0.000 description 5
- 210000000038 chest Anatomy 0.000 description 5
- 230000008602 contraction Effects 0.000 description 5
- 230000000916 dilatatory effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 230000002443 hepatoprotective effect Effects 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 244000063299 Bacillus subtilis Species 0.000 description 3
- 235000014469 Bacillus subtilis Nutrition 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 239000000812 cholinergic antagonist Substances 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 206010016766 flatulence Diseases 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 231100000957 no side effect Toxicity 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000036284 oxygen consumption Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002460 smooth muscle Anatomy 0.000 description 3
- 230000002048 spasmolytic effect Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 210000003932 urinary bladder Anatomy 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 206010019909 Hernia Diseases 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- AXVZFRBSCNEKPQ-UHFFFAOYSA-N N-methyltyramine Chemical compound CNCCC1=CC=C(O)C=C1 AXVZFRBSCNEKPQ-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000191963 Staphylococcus epidermidis Species 0.000 description 2
- 241000193998 Streptococcus pneumoniae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 208000023652 chronic gastritis Diseases 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- -1 luteolin glycosides Chemical class 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000008327 renal blood flow Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000003867 tiredness Effects 0.000 description 2
- 208000016255 tiredness Diseases 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- FTVWIRXFELQLPI-ZDUSSCGKSA-N (S)-naringenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC(O)=C2C(=O)C1 FTVWIRXFELQLPI-ZDUSSCGKSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000012657 Atopic disease Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 241000588832 Bordetella pertussis Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 235000017159 Crataegus pinnatifida Nutrition 0.000 description 1
- 241000657480 Crataegus pinnatifida Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012895 Gastric disease Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 208000036581 Haemorrhagic anaemia Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 208000008081 Intestinal Fistula Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010062104 Renal mass Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000531795 Salmonella enterica subsp. enterica serovar Paratyphi A Species 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 description 1
- 244000126002 Ziziphus vulgaris Species 0.000 description 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000006286 aqueous extract Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
- 229960004484 carbachol Drugs 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 206010007625 cardiogenic shock Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 108010084210 citrin Proteins 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000000147 hypnotic effect Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 229960001438 immunostimulant agent Drugs 0.000 description 1
- 239000003022 immunostimulating agent Substances 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229940117954 naringenin Drugs 0.000 description 1
- WGEYAGZBLYNDFV-UHFFFAOYSA-N naringenin Natural products C1(=O)C2=C(O)C=C(O)C=C2OC(C1)C1=CC=C(CC1)O WGEYAGZBLYNDFV-UHFFFAOYSA-N 0.000 description 1
- 235000007625 naringenin Nutrition 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 210000004203 pyloric antrum Anatomy 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000015339 staphylococcus aureus infection Diseases 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000036977 tonic contraction Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention provides a traditional Chinese medicine composition for treating antral gastritis. The traditional Chinese medicine composition for treating antral gastriti is characterized in that the traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 30-60 parts of raw hawthorn, 15-35 parts of raw radix paeoniae alba, 5-15 parts of cassia twig, 15-35 parts of grifola, 15-35 parts of mangnolia officinalis, 10-20 parts of pericarpium citri reticulatae viride, 10-20 parts of codonopsis pilosula, 10-20 parts of radix scutellariae, 5-15 parts of honeysuckle flower, 5-15 parts of fructus aurantii immaturus, 5-15 parts of radix bupleuri and 5-20 parts of red jujube. The traditional Chinese medicine raw materials of the traditional Chinese medicine composition have the advantages of reasonable compatibility, synergetic medicine effect, obvious treatment effect on antral gastritis, functions of consolidating body resistance and nourishing vigour, no toxic or side effects, low treatment cost and the like.
Description
Technical field:
The present invention relates to Chinese medicine technical field, is exactly specifically a kind of Chinese medicine composition for the treatment of antral gastritis.
Background technology:
Antral gastritis refers to a kind of chronic inflammatory disease that is confined to gastric antrum portion, and major lesions is confined to mucous layer more, but also stretches to flesh layer or placenta percreta.Lesion portion occur edema, inflammatory cell invade profit and proliferation of fibrous tissue, make local thickening, even narrow; Some cases can have mucous membrane surface erosion, enteraden epithelization to change.Antral gastritis is apt to occur in 30 years old above male, shows as epigastrium glutted, and dull pain or severe pain, be often periodical attack, can be with belch, acid regurgitation, vomiting, poor appetite, become thin etc., and chronic gastritis also can show as anorexia, persistence stomachache, hemorrhagic anemia etc.The treatment of antral gastritis generally should adopt the measures such as diet control, calmness, antiacid, spasmolytic, pain relieving, although it is a lot of to treat the Western medicine of antral gastritis, larger from curative effect difference, also has significantly and has no side effect.
Summary of the invention: the technology of the present invention is in order to overcome deficiency of the prior art, provide a kind for the treatment of for antral gastritis have curative effect obviously, vital base and primordial QI consolidating, have no side effect, and medical expense is cheap.
The invention provides following technical scheme:
Treat a Chinese medicine composition for antral gastritis, it is characterized in that being made by the raw material of Chinese medicine of following weight proportion: Fructus Crataegi 30-60 part, Radix Paeoniae Alba 15-35 part, Ramulus Cinnamomi 5-15 part, Polyporus 15-35 part, Cortex Magnoliae Officinalis 15-35 part, Pericarpium Citri Reticulatae Viride 10-20 part, Radix Codonopsis 10-20 part, Radix Scutellariae 10-20 part, Flos Lonicerae 5-15 part, Fructus Aurantii Immaturus 5-15 part, Radix Bupleuri 5-15 part, Fructus Jujubae 5-20 part..
Optimization formula is as follows:
50 parts of Fructus Crataegi, 20 parts of Radix Paeoniae Alba, 10 parts of Ramulus Cinnamomi, 20 parts of Polyporus, 20 parts of Cortex Magnoliae Officinalis, 15 parts, Pericarpium Citri Reticulatae Viride, 15 parts of Radix Codonopsis, 15 parts of Radix Scutellariaes, 10 parts of Flos Lonicerae, 10 parts of Fructus Aurantii Immaturuss, 5 parts of Radix Bupleuri, 12 parts of Fructus Jujubaes..
Form being described as follows of various raw material of Chinese medicine of the present invention:
Fructus Crataegi: sour in the mouth is sweet, slightly warm in nature.Return spleen, stomach, Liver Channel.Have help digestion long-pending, dissipating blood stasis blood, the effects such as expelling tenia.Be usually used in meat long-pending, lump in the abdomen, phlegm retention, feeling of fullness, acid regurgitation, dysentery, hemorrhoidal hamorrhage, lumbago, hernia after-pains in puerperal, lochiorrhea, children's's breast food is stagnated.Promoting digestion and invigorating the stomach, circulation of qi promoting dissipating blood stasis, the diseases such as meat stagnation, stomach alkane distension, dysentery stomachache, blood stasis amenorrhea, postpartum stagnation, trusted subordinate's twinge, hernia pain, hyperlipidemia.Fructus Crataegi has skin care weight reducing, and woman's weight-reducing tablet Fructus Crataegi contains the generation that free radical was blocked and reduced to the substances such as vitamin C, carotene, and the immunity of energy enhancing body, has anti-aging, anticancer effect; Women eats the effect that Fructus Crataegi can be eliminated body fat, be reduced fat absorption more, can reach the effect of U.S. face weight reducing for the women who likes to be beautiful.Fructus Crataegi has blood pressure lowering, blood fat reducing, and antioxidation, enhancing immunity, removes gastrointestinal tract noxious bacteria etc., also can prevent liver cancer.Male obtained fatty liver, will nourishing the liver hepatoprotective, and nourishing the liver hepatoprotective, first-elected Fructus Crataegi.Fructus Crataegi, can be aid digestion, has nourishing the liver degrease effect.Fructus Crataegi can significantly reduce serum cholesterol and triglyceride, effectively prevents and treats atherosclerosis; Fructus Crataegi can also play heart tonifying and prevent anginal effect by strengthening myocardial contraction, increase cardiac output, coronary artery dilator blood vessel, increase coronary flow, reduction myocardial oxygen consumption etc.In addition, the total flavones in Fructus Crataegi has the effect of blood vessel dilating and lasting blood pressure lowering.Fructus Crataegi has the effect of activating blood circulation to dissipate blood stasis, is blood stasis type dysmenorrhea patient's dietetic therapy good merchantable brand.
The Radix Paeoniae Alba: cool in nature, bitter in the mouth acid, is slightly cold, and has blood-supplementing blood-nourishing, suppressing liver-YANG, easing the affected liver to relieve pain.The effects such as astringing YIN to stop sweating, are applicable to fever due to yin deficiency, menoxenia, the breast abdomen pain over the hypochondriac region, extremity contraction anxious, dysentery stomachache, spontaneous sweating, metrorrhagia, are with inferior disease.In this product, contained paeoniflorin has antibacterial, antipyretic, antiinflammatory, increase coronary flow, improves the effect of myocardial nutritional flow, blood vessel dilating, antagonism acute myocardial ischemia, anticoagulant, calmness, analgesia, spasmolytic, antiulcer, adjusting blood glucose; Radix Paeoniae Alba decoct can suppress dysentery bacterium, streptococcus pneumoniae, escherichia coli, Bacillus typhi, Hemolytic streptococcus, bacillus pyocyaneus etc.In addition, research shows: the Radix Paeoniae Alba has potentiation to the phagocytic function of macrophage.
Ramulus Cinnamomi: acrid in the mouth, sweet, warm in nature.GUIXIN, lung, urinary bladder channel.There is diaphoresis expelling pathogenic factors from muscles, warming the meridian and promoting blood circulation, supporing yang activating QI, the effects such as dispersing cold for relieving pain.Be usually used in anemofrigid cold, coldness and pain in the epigastrium, cold in blood amenorrhea, arthralgia, phlegm retention, edema, cardiopalmus, the diseases such as renal mass.This product also has blood vessel dilating, regulates blood circulation, antipyretic, analgesia, calmness, convulsion, antiinflammatory, antiallergic, the effect such as antibacterial.
Polyporus: sweet in the mouth, light, property is flat.Return kidney, urinary bladder channel.There is the effects such as promoting diuresis to eliminate damp pathogen.Be usually used in dysuria, edema, has loose bowels, and stranguria with turbid discharge is with inferior disease.This product also has diuresis, immunostimulant, antitumor, liver is had to significant protective effect, radioprotective, and the alcohol extract of Polyporus has the effects such as inhibition to staphylococcus aureus, escherichia coli.
Cortex Magnoliae Officinalis: bitter in the mouth; Pungent; Warm in nature.Return spleen, stomach, large intestine channel.There is circulation of qi promoting removing food stagnancy; Dampness is except full; The effects such as lowering the adverse QI to relieve asthma.Be mainly used in treating stagnation of QI due to dyspepsia; Abdominal distention constipation; Retention of dampness in middle-JIAO, gastral cavity painful abdominal mass is vomited and diarrhoea; Expectorant is stopped up QI rising in reverse order; The fullness in the chest disease such as breath with cough.This product experiment in vitro proves, Cortex Magnoliae Officinalis decoct all has antibacterial action to gram negative bacillis such as the gram positive bacterias such as staphylococcus, Hemolytic streptococcus, streptococcus pneumoniae, bordetella pertussis and anthrax bacillus, dysentery bacterium, Bacillus typhi, Salmonella paratyphi, vibrio cholera, escherichia coli, Bacillus proteus, bacillus subtilis.Experiment shows, with other 61 kinds of Chinese medicines, compares, and Cortex Magnoliae Officinalis is the strongest to the effect of Staphylococcus albus, bacillus subtilis, escherichia coli and Bacillus typhi, its bactericidal action that act as to Staphylococcus albus and bacillus subtilis.In addition, the intestine in vitro of Cortex Magnoliae Officinalis decoct to mice and Cavia porcellus, low dose of appearance is excited, and heavy dose, for suppressing, also has excitation to guinea pig bronchial smooth muscle.
Pericarpium Citri Reticulatae Viride: bitter in the mouth, pungent, warm in nature.Return liver, gallbladder, stomach warp.There is soothing the liver dispelling the stagnated QI, the effect such as removing food stagnancyization is stagnant.Be usually used in distending pain in the chest and hypochondrium, hernia, nodule in the breast, acute mastitis, the diseases such as abdominal pain due to retention of food.Pericarpium Citri Reticulatae Viride injection can reduce the tonic contraction of in vitro Guinea pig Gastric, intestinal, gallbladder and Mouse Uterus, and make smooth muscle of bladder excited, the gallbladder contraction that guinea pig in vitro stomach, intestinal and the rabbit that acetylcholine is caused causes at body pipe smooth muscle and carbachol, has the spasmolysis showing.In addition, also have boosting, and can excitedly breathe, and the effect such as shock.
Radix Codonopsis: sweet in the mouth, property is flat.Return spleen, lung meridian.There is invigorating the spleen and replenishing QI, the effects such as spleen invigorating lung benefiting.Be usually used in deficiency of the spleen and lung, the cardiopalmus of breathing hard, anorexia and loose stool, dyspnea due to deficiency cough, the interior-heat disease such as quench one's thirst.The alcohol of Radix Codonopsis root, aqueous extract is oral or subcutaneous injection, can make the erythrocyte of normal rabbit and the effect that hemoglobin slightly increases.In addition, also there is the effects such as blood sugar lowering, blood pressure lowering.
Radix Scutellariae: bitter in the mouth, cold in nature.Return lung, gallbladder, spleen, large intestine, small intestine meridian.There is heat clearing and damp drying, eliminating fire and detoxication, hemostasis, the effect such as antiabortive.Be usually used in hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, dysentery, jaundice, cough due to lung-heat, high hot excessive thirst, heat in blood is told nosebleed, carbuncle sore tumefacting virus, the diseases such as frequent fetal movement.The effects such as that this product also has is antibacterial, antifungal, antiviral, antiplatelet aggregation and anticoagulant, antiinflammatory antiallergic action, antimicrobial, antipyretic, blood pressure lowering, diuresis and gallbladder, spasmolytic, calmness.In addition, the clinical antibiotic property of Radix Scutellariae is better than Rhizoma Coptidis, and does not develop immunity to drugs.
Flos Lonicerae: sweet in the mouth, cold in nature.Return lung, the heart, stomach warp.There is heat-clearing and toxic substances removing, the effects such as wind-heat dissipating.Be usually used in carbuncle furuncle, sore throat, erysipelas, toxic-heat and blood stasis, anemopyretic cold, the diseases such as epidemic febrile disease heating.Flos Lonicerae contains the pharmacological components such as chlorogenic acid, luteolin glycosides, the various pathogens such as Hemolytic streptococcus, staphylococcus aureus and upper respiratory tract infection Causative virus etc. are had to stronger restraint, in addition also can enhancing immunity, antiearly pregnancy, hepatoprotective, antitumor, antiinflammatory, antipyretic, hemostasis, suppress the effects such as intestinal absorption cholesterol.
Fructus Aurantii Immaturus: bitter in the mouth, pungent, sour, warm in nature.Return spleen, stomach warp.There is dispelling the stagnated QI removing food stagnancy, the effects such as loose painful abdominal mass of reducing phlegm.In being usually used in stagnating, stop, feeling of fullness distending pain, heavy after dysentery, constipation, the stagnant vapour lock thoracic obstruction of expectorant, blocked-up chest; Gastroptosis, proctoptosis, the diseases such as uterine prolapse.Fructus Aurantii Immaturus has impact to brain, kidney and coronary flow; When increasing coronary flow more significantly, myocardial oxygen consumption slightly increases but is not obvious, does not parallel with the remarkable increase of coronary flow; Have more by force and more lasting boosting; Have and shrink peripheral vessels, reduce Peripheral blood circulating load, reduce selectively again brain, kidney and coronary resistance, increase the effect of main vital organ blood flow, and have and dwindle to a certain extent spleen volume phenomenon simultaneously.When increasing renal blood flow, urine amount slightly increases.After Fructus Aurantii Immaturus intravenously administrable, heart rate slightly increases.The disorderly phenomenon of ectopic cardiac rhythm, generally occurs few. and be improved myocardial metabolism, the effect of strengthening myocardium shrinkage function and improving blood pressure, increase pulse pressure.These features, have the certain significance to treatment cardiogenic shock.There are some researches prove, Fructus Aurantii Immaturus injection, for various shock states, has the satisfied shock curative effect of boosting.During effective ingredient N-methyltyramine low concentration venous perfusion wherein, not obvious, speed heart rate in the situation that, can make coronary flow significantly increase, coronary resistance significantly reduces, and makes myocardium oxygen consumption reduce simultaneously; Increasing renal blood flow, reduce renal vascular resistance, and have significant diuresis effect. these effects are all very favourable for shock.In addition, the water decoction of Fructus Aurantii Immaturus, Fructus Aurantii, tincture and fluid extract all have inhibitory action to the intestine in vitro of mice, rabbit and rabbit at body intestinal tube. and it is strong that decocting liquid makes the gastrointestinal of stomach, intestinal fistula Canis familiaris L. shrink the rhythm and pace of moving things, being excitation, but suppressing Canis familiaris L. at body gastrointestinal motility. Furctus Aurantii Immaturus extract shrinks and has obvious antagonism intestinal tube due to acetylcholine and histamine.
Radix Bupleuri: bitter in the mouth, cold nature.Return liver, gallbladder meridian.There is reconciling superficies and interior, soothing the liver, the effects such as yang invigorating.Be usually used in cold, fever, alternate attack of chill and fever, distending pain in the chest and hypochondrium, menoxenia, sub-official's prolapsus, the diseases such as proctoptosis.The effects such as that this product also has is antipyretic, antiinflammatory, Promote immunity function, anti-liver injury, Antiradiation injury.
Fructus Jujubae: sweet in the mouth, warm in nature.Return spleen, stomach warp.Have spleen reinforcing stomach function regulating, supplementing QI for promoting the production of body fluid, adjusts battalion to defend, and separates the effects such as poison of drug.Be commonly used to treat insufficiency of stomach lack of appetite, the weak loose stool of spleen, qi-blood-body fluid is not enough, disharmony of nutrient QI with defensive QI, severe palpitation.The hot-tempered grade of married woman's stolen goods disease.This product has the function of invigorating the spleen and replenishing QI, nourishing blood to tranquillize the mind, the mitigation property of medicine; Modern pharmacology finds, it is multiple that Fructus Jujubae contains protein, fat, carbohydrate, organic acid, vitamin A, vitamin C, micro-calcium.Fructus Jujubae can improve body immunity, and can anticancer: pharmacological research finds, Fructus Jujubae can promote leukocytic generation; reduce serum cholesterol, improve serum albumin, the liver protecting; in Fructus Jujubae, also contain anticancer, the material that even can make cancerous cell transform to normal cell.The people of often edible fresh Fructus Jujubae seldom suffers from cholelithiasis, and this is because of abundant vitamin C in fresh Fructus Jujubae, makes unnecessary cholesterol in body change bile acid into, little cholesterol, lithogenous probability also just reduces thereupon.In Fructus Jujubae, be rich in calcium and ferrum; they to preventing and treating osteoporosis, postpartum anemia plays an important role; middle-aged and elderly people frequent meeting of climacteric osteoporosis; easily there is anemia in teenager and the women on growth promoter peak just; Fructus Jujubae has very good dietary function to them, and its effect normally medicine can not compared.The people of body void after being ill is also had to good tonic effect.The rutin that Fructus Jujubae is contained, is a kind of arteriosclerosis that makes, thereby makes the material of Blood pressure drop, and hypertension is had to prophylactic-therapeutic effect.Fructus Jujubae can also antiallergic, except stench strange taste, mind tranquilizing and the heart calming, brain healthy, appetite strengthening.Fructus Jujubae can also be well can muscle strength reinforcing, allaying tiredness, blood vessel dilating, increase myocardial contraction, improve myocardial nutrition.Fructus Jujubae contains a large amount of glucides, is mainly glucose, also contains fructose, sucrose, and the oligosaccharide being comprised of glucose and fructose, arabinan and galacturonan etc.; And contain the multivitamins such as a large amount of vitamin Cs, riboflavin, thiamine, carotene, nicotinic acid, and there is stronger tonic effect, can improve immune function of human body, strengthen resistance against diseases.The effect that Fructus Jujubae has muscle strength reinforcing and puts on weight.Fructus Jujubae has hepatoprotective effect.Fructus Jujubae ethanol extraction, to atopic diseases, can suppress the generation of antibody, and mice reactive antibody is also had to inhibitory action, and prompting Fructus Jujubae has anti-allergy action.Contained flavone in Fructus Jujubae--two-glycoside A has calmness, hypnosis and hypotensive effect, the naringenin C glucoside being wherein separated has central inhibitory action, reduce autonomic movement and stimulate reflection, tetanic numb effect, thus Fructus Jujubae have calm the nerves, the merit of calmness.Fructus Jujubae is containing multiple three these compounds, and wherein firelight or sunlight wood acid, crataegus pin natifida var. Major acid all find that there is active anticancer, and to sarcoma, S-180 has inhibitory action.Contained nutrient in Fructus Jujubae, can strengthen immune function of human body, for cancer-resisting with maintain human-body viscera function and have certain effect.Fructus Jujubae claims again Fructus Jujubae, dry Fructus Jujubae, Chinese date etc.The compositions such as Fructus Jujubae rich in proteins, fat, saccharide, carotene, vitamin B group, vitamin C, Citrin and phosphorus, calcium, ferrum, wherein ascorbic content comes out at the top in fruit, has the laudatory title of " natural complex ball ".The cyclic adenosine monophosphate that Fructus Jujubae is rich in, is the essential material of human energy metabolism, can muscle strength reinforcing, allaying tiredness, blood vessel dilating, increase myocardial contraction, improve myocardial nutrition, prevention and cure of cardiovascular disease is had to good effect.Fructus Jujubae has the effects such as tonify deficiency QI invigorating, nourishing blood to tranquillize the mind, invigorating the spleen and regulating the stomach, is the good health nutrients of patient such as weakness of the spleen and stomach, insufficiency of vital energy and blood, lassitude, insomnia.Fructus Jujubae has good therapeutic effect to diseases such as acute, chronic hepatitis, liver cirrhosis, anemia, anaphylactoid purpura.Fructus Jujubae contains triterpenoid compound and cyclic adenosine monophosphate, has stronger cancer, the anti-allergic effects of pressing down.
The invention has the advantages that:
Form each raw material of Chinese medicine compatibility of the present invention reasonable, drug effect is collaborative, for the treatment of antral gastritis have curative effect obviously, vital base and primordial QI consolidating, have no side effect, and the advantage such as medical expense is cheap.
The specific embodiment:
Embodiment 1:
Treat a Chinese medicine composition for antral gastritis, it is characterized in that being made by the raw material of Chinese medicine of following weight proportion: 50 parts of Fructus Crataegi, 20 parts of Radix Paeoniae Alba, 10 parts of Ramulus Cinnamomi, 20 parts of Polyporus, 20 parts of Cortex Magnoliae Officinalis, 15 parts, Pericarpium Citri Reticulatae Viride, 15 parts of Radix Codonopsis, 15 parts of Radix Scutellariaes, 10 parts of Flos Lonicerae, 10 parts of Fructus Aurantii Immaturuss, 5 parts of Radix Bupleuri, 12 parts of Fructus Jujubaes..
Embodiment 2:
Treat a Chinese medicine composition for antral gastritis, it is characterized in that being made by the raw material of Chinese medicine of following weight proportion: 30 parts of Fructus Crataegi, 15 parts of Radix Paeoniae Alba, 8 parts of Ramulus Cinnamomi, 15 parts of Polyporus, 15 parts of Cortex Magnoliae Officinalis, 10 parts, Pericarpium Citri Reticulatae Viride, 10 parts of Radix Codonopsis, 10 parts of Radix Scutellariaes, 8 parts of Flos Lonicerae, 10 parts of Fructus Aurantii Immaturuss, 10 parts of Radix Bupleuri, 5 parts of Fructus Jujubaes..
Embodiment 3:
Treat a Chinese medicine composition for antral gastritis, it is characterized in that being made by the raw material of Chinese medicine of following weight proportion: 45 parts of Fructus Crataegi, 30 parts of Radix Paeoniae Alba, 15 parts of Ramulus Cinnamomi, 30 parts of Polyporus, 35 parts of Cortex Magnoliae Officinalis, 20 parts, Pericarpium Citri Reticulatae Viride, 20 parts of Radix Codonopsis, 20 parts of Radix Scutellariaes, 15 parts of Flos Lonicerae, 15 parts of Fructus Aurantii Immaturuss, 15 parts of Radix Bupleuri, 20 parts of Fructus Jujubaes..
Embodiment 1-3 all adopts the preparation of Chinese medicine traditional method, and every day, potion decocted 3 times, and the morning, noon and afternoon service once, and taking continuously 1 week is a course for the treatment of.
Model case:
Slowly * *, man, 39 years old, suffers from antral gastritis 3 years, recently because flu causes antral gastritis, increase the weight of, successively take Western medicine and Chinese patent medicine is alleviated to some extent, but the state of an illness is very unstable, epigastric often has the swollen sense of support, dull pain, acid regurgitation water, feel sick, the poor symptom of appetite, takes the swollen sense of 3 back braces course for the treatment of of the present invention, feel sick and alleviate, dull pain, acid regurgitation water is alleviated, after taking 4 courses for the treatment of, appetite strengthens again, other transference cures, recovery from illness.
Lu * *, female, 42 years old, suffers from antral gastritis for many years.Frequent acid regurgitation water, flatulence pain, feels sick, anorexia, health is day by day become thin, and Chinese and western medicine has all been seen, medicine has also been eaten many, but 3 courses for the treatment of of the present invention are taken in still bad outbreak repeatedly during fashion of the state of an illness, flatulence pain, nauseating symptom alleviates, acid regurgitation water transference cure, take after 5 courses for the treatment of, appetite is improved again, and sb.'s illness took a favorable turn, stable, follow up a case by regular visits to, not recurrence.
Xiao * *, man, 36 years old, suffers from chronic gastritis for many years, normal sending out felt sick, and the stomach dull pain of swelling, just eats raw flower rice and alleviate during acid regurgitation water, also ate the medicine that some control gastropathy, but fail radical cure always, take 4 courses for the treatment of of the present invention after flatulence alleviation of pain light, only feel sick acid regurgitation water retention.Take again 3 the course for the treatment of each transference cure, recovery from illness.
Claims (2)
1. treat a Chinese medicine composition for antral gastritis, it is characterized in that being made by the raw material of Chinese medicine of following weight proportion: Fructus Crataegi 30-60 part, Radix Paeoniae Alba 15-35 part, Ramulus Cinnamomi 5-15 part, Polyporus 15-35 part, Cortex Magnoliae Officinalis 15-35 part, Pericarpium Citri Reticulatae Viride 10-20 part, Radix Codonopsis 10-20 part, Radix Scutellariae 10-20 part, Flos Lonicerae 5-15 part, Fructus Aurantii Immaturus 5-15 part, Radix Bupleuri 5-15 part, Fructus Jujubae 5-20 part..
2. according to a kind of Chinese medicine composition for the treatment of antral gastritis described in claim 1, it is characterized in that being made by the raw material of Chinese medicine of following weight proportion: 50 parts of Fructus Crataegi, 20 parts of Radix Paeoniae Alba, 10 parts of Ramulus Cinnamomi, 20 parts of Polyporus, 20 parts of Cortex Magnoliae Officinalis, 15 parts, Pericarpium Citri Reticulatae Viride, 15 parts of Radix Codonopsis, 15 parts of Radix Scutellariaes, 10 parts of Flos Lonicerae, 10 parts of Fructus Aurantii Immaturuss, 5 parts of Radix Bupleuri, 12 parts of Fructus Jujubaes..
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410372182.5A CN104107245B (en) | 2014-07-31 | 2014-07-31 | A kind of Chinese medicine composition treating antral gastritis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410372182.5A CN104107245B (en) | 2014-07-31 | 2014-07-31 | A kind of Chinese medicine composition treating antral gastritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104107245A true CN104107245A (en) | 2014-10-22 |
| CN104107245B CN104107245B (en) | 2016-07-06 |
Family
ID=51704364
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410372182.5A Expired - Fee Related CN104107245B (en) | 2014-07-31 | 2014-07-31 | A kind of Chinese medicine composition treating antral gastritis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104107245B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920297A (en) * | 2016-05-13 | 2016-09-07 | 晋利华 | Combined medicine for treating antral gastritis through combination of traditional Chinese medicine and western medicine |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1137384A (en) * | 1995-06-02 | 1996-12-11 | 周国华 | Changweiling medicine for curing enterogastritis |
| CN1739783A (en) * | 2005-09-16 | 2006-03-01 | 王俊 | Chinese medicine composition for treating gastritis, gastric ulcer and duodenal ulcer |
-
2014
- 2014-07-31 CN CN201410372182.5A patent/CN104107245B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1137384A (en) * | 1995-06-02 | 1996-12-11 | 周国华 | Changweiling medicine for curing enterogastritis |
| CN1739783A (en) * | 2005-09-16 | 2006-03-01 | 王俊 | Chinese medicine composition for treating gastritis, gastric ulcer and duodenal ulcer |
Non-Patent Citations (1)
| Title |
|---|
| 邓永启等: "半夏厚朴汤加味治疗胃窦炎34例", 《吉林中医药》, no. 02, 31 December 1997 (1997-12-31) * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105920297A (en) * | 2016-05-13 | 2016-09-07 | 晋利华 | Combined medicine for treating antral gastritis through combination of traditional Chinese medicine and western medicine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104107245B (en) | 2016-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104509619A (en) | Traditional Chinese medicine fat-reducing healthy tea and preparation method thereof | |
| CN101069723A (en) | Oral liquor of anti-fatigue and intensifying immunity and preparing method | |
| CN104825801A (en) | TCM (traditional Chinese medicine) preparation for preventing and treating cardiovascular and cerebrovascular diseases | |
| CN102920870A (en) | Hawthorn capsule for improving digestion and harmonizing stomach | |
| CN103005264B (en) | Chitosan oligosaccharide-containing healthcare food and preparation method thereof | |
| CN105012735B (en) | One kind fills blood anticancer traditional Chinese medicinal composition | |
| CN101966297A (en) | Compound common macrocarpium fruit ginseng leaf decoction for treating vertigo | |
| CN104107245B (en) | A kind of Chinese medicine composition treating antral gastritis | |
| CN103505530A (en) | Traditional Chinese medicine composition for treating variability measles | |
| CN1044965C (en) | Sand pear beverage | |
| CN102895392B (en) | Chinese medicine for treating duodenal ulcer | |
| CN104840686A (en) | Blood-pressure reduction type health-care tea | |
| CN104524358A (en) | Pills for adjuvant treatment of iron-deficiency anemia and preparation method thereof | |
| CN104083748A (en) | Traditional Chinese medicine formula for treating sour regurgitation caused by deficiency of gastric dynamics | |
| CN104127753A (en) | Traditional Chinese medicine tea bag for treating gouty arthritis and preparation method thereof | |
| CN101810751B (en) | Chinese medicinal preparation for treating pediatric mesenteric lymph node inflammation | |
| CN1781546A (en) | Recovery mixture for liver, gallbladder and stomach and its preparing method | |
| CN101019979B (en) | Lactation promoting health product | |
| CN101822764A (en) | External patch for treating children anorexia and preparation method thereof | |
| CN106729570A (en) | Clearing damp removes hot anti-inflammatory soup | |
| CN104840574B (en) | A kind of Chinese medicine composition for treating hepatopathy and preparation method thereof | |
| CN103893740A (en) | Traditional Chinese medicine for treating chronic colitis | |
| CN103720870A (en) | Traditional Chinese medicament preparation for treating myocarditis and preparation method thereof | |
| CN104189638A (en) | Traditional Chinese medicine preparation for treating spleen-deficiency diarrhea | |
| CN103705886B (en) | A kind of pylorus of preventing and treating does not obstruct stifled Chinese medicinal granule entirely |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 233000 Xinghua Road 189, Bengbu High-tech Zone, Anhui Province Patentee after: BENGBU HUOHE PHARMACEUTICAL CO.,LTD. Address before: 233000 No. 200 Changqing South Road, Bengbu High-tech Development Zone, Anhui Province Patentee before: BENGBU HUOHE PHARMACEUTICAL Co.,Ltd. |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Traditional Chinese medicine composition for treating antral gastritis Effective date of registration: 20200520 Granted publication date: 20160706 Pledgee: Bengbu Science and Technology Financing Guarantee Co.,Ltd. Pledgor: BENGBU HUOHE PHARMACEUTICAL Co.,Ltd. Registration number: Y2020980002340 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20160706 |